PT1337236E - Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas - Google Patents

Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas

Info

Publication number
PT1337236E
PT1337236E PT01994656T PT01994656T PT1337236E PT 1337236 E PT1337236 E PT 1337236E PT 01994656 T PT01994656 T PT 01994656T PT 01994656 T PT01994656 T PT 01994656T PT 1337236 E PT1337236 E PT 1337236E
Authority
PT
Portugal
Prior art keywords
supplement
parenteric
nutriental
enterical
chronic
Prior art date
Application number
PT01994656T
Other languages
English (en)
Inventor
Barbara Kessler
Angelika Riedel
Ulrich Suchner
Original Assignee
Fresenius Kabi De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh
Publication of PT1337236E publication Critical patent/PT1337236E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT01994656T 2000-11-17 2001-11-14 Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas PT1337236E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10057290A DE10057290B4 (de) 2000-11-17 2000-11-17 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten

Publications (1)

Publication Number Publication Date
PT1337236E true PT1337236E (pt) 2004-11-30

Family

ID=7663817

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01994656T PT1337236E (pt) 2000-11-17 2001-11-14 Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas

Country Status (28)

Country Link
US (1) US7947303B2 (pt)
EP (1) EP1337236B1 (pt)
JP (1) JP2004513912A (pt)
KR (2) KR20080069280A (pt)
CN (1) CN1477950A (pt)
AT (1) ATE272390T1 (pt)
AU (2) AU2002224848B2 (pt)
BR (1) BRPI0115451B1 (pt)
CA (1) CA2429270C (pt)
CZ (1) CZ300129B6 (pt)
DE (2) DE10057290B4 (pt)
DK (1) DK1337236T3 (pt)
EE (1) EE05209B1 (pt)
ES (1) ES2223015T3 (pt)
HR (1) HRP20030395B1 (pt)
HU (1) HU228351B1 (pt)
IL (2) IL155840A0 (pt)
IS (1) IS2377B (pt)
MX (1) MXPA03004348A (pt)
NO (1) NO333003B1 (pt)
NZ (1) NZ525812A (pt)
PL (1) PL202031B1 (pt)
PT (1) PT1337236E (pt)
RU (1) RU2295952C2 (pt)
SI (1) SI1337236T1 (pt)
SK (1) SK286199B6 (pt)
WO (1) WO2002039978A1 (pt)
ZA (1) ZA200303722B (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
US20070026090A1 (en) * 2003-09-05 2007-02-01 Oren Tirosh Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
WO2005027660A2 (en) * 2003-09-19 2005-03-31 N.V. Nutricia Method and composition for preventing multiple organ dysfunction syndrome
DE10349585A1 (de) * 2003-10-24 2005-06-16 Biosyn Arzneimittel Gmbh Spurenelementzusammensetzung für die Ernährung
DE202004015931U1 (de) * 2004-10-13 2005-01-05 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung
US20050148669A1 (en) * 2004-10-21 2005-07-07 Daniel Amato Amino acid esters as nutrient supplements and methods of use
WO2006053010A2 (en) * 2004-11-09 2006-05-18 Hill's Pet Nutrition, Inc. Use of antioxidants for gene modulation
BRPI0519755A2 (pt) * 2004-12-21 2009-03-10 Critical Care Connections Inc composiÇÕes ou combinaÇÕes nutrientes terapÊuticas e uso dos mesmos
DK2258219T4 (da) 2005-04-27 2022-08-29 Nutricia Nv Næring med lipider og ikke-fordøjelige saccharider
EP1719543A1 (en) * 2005-05-04 2006-11-08 Asan Labs., Ltd. Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
WO2006127695A2 (en) * 2005-05-23 2006-11-30 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Ascorbic acid conjugates
MX2008002701A (es) * 2005-08-26 2008-03-18 Nestec Sa Nutricion para pacientes obesos.
DE102005046237A1 (de) * 2005-09-28 2007-04-05 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen
BRPI0618599A2 (pt) * 2005-11-15 2011-09-06 Entress Ab uso de um ácido alfa-cetoglutárico ou de um sal farmaceuticamente aceitável de ácido alfa-cetoglutárico
CN101365350A (zh) * 2006-01-09 2009-02-11 雀巢技术公司 应激患者的治疗
EP2032170B1 (en) * 2006-06-14 2012-11-28 N.V. Nutricia Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
KR100774816B1 (ko) * 2006-11-21 2007-11-07 동부일렉트로닉스 주식회사 반도체 소자의 ｍｉｍ 커패시터 제조 방법 및 구조
EP3263120A1 (en) * 2007-09-17 2018-01-03 N.V. Nutricia Nutritional formulation with high energy content
EP2205235A4 (en) * 2007-10-14 2010-11-17 Univ Florida PREPARATION TO IMPROVE GASTROINTESTINAL FUNCTION
IT1396935B1 (it) * 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
BR112012027427A2 (pt) * 2010-04-26 2015-09-15 Nestec Sa composições nutritivas e métodos para a mudança da nutrição parenteral para a nutrição enteral
RU2013148525A (ru) * 2011-03-31 2015-05-10 Нестек С.А. Питательные композиции для увеличения уровней аргинина и способы их применения
EP2705844B1 (en) 2011-04-13 2019-05-22 Ajinomoto Co., Inc. Nutritional composition
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
US9849144B2 (en) 2013-09-16 2017-12-26 Healios Oncology Nutrition, LLC Glutamine and trehalose compositions
JP6841223B2 (ja) 2015-06-10 2021-03-10 味の素株式会社 運動誘発性の消化管障害の改善剤
ES2638195B1 (es) 2016-04-18 2018-08-02 Bioiberica, S.A. Composiciones para la piel
WO2018208593A1 (en) 2017-05-09 2018-11-15 Baxter International Inc. Parenteral nutrition diagnostic system, apparatus, and method
CN108208177A (zh) * 2017-11-28 2018-06-29 上海交通大学医学院附属新华医院 含丁酸类化合物的组合物及其应用
PL423673A1 (pl) * 2017-12-01 2019-06-03 Lewandowska Agata Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
US11666548B2 (en) * 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation
US20220160669A1 (en) 2020-11-24 2022-05-26 Baxter International Inc. Parenteral nutrition formulation
DE202021102589U1 (de) 2020-12-15 2021-05-28 Marco Lautenschläger Verzehrfertiges, abgefülltes Getränk auf Basis eines natürlichen Mineralwassers
WO2023205635A1 (en) * 2022-04-19 2023-10-26 Vanderbilt University Compositions and methods of treatment for congenital diarrheal disorder
WO2023215458A1 (en) * 2022-05-06 2023-11-09 Ageless Sciences, Inc. Compositions and methods for slowing down aging and extending lifespan
CN116920075B (zh) * 2023-09-15 2024-01-02 潍坊市人民医院(潍坊市公共卫生临床中心) 一种肠内营养液及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3698912A (en) * 1969-07-01 1972-10-17 Morton Norwich Products Inc Process for making nutrient composition
DE3135849A1 (de) * 1981-09-10 1983-03-17 Dr. Schumacher GmbH & Co KG, 4600 Dortmund Beschichtungsstoff fuer korrosionsschutzzwecke
US4446389A (en) * 1982-03-15 1984-05-01 Ampex Corporation Quadrature tach decoder circuit
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JP2524551B2 (ja) * 1992-02-28 1996-08-14 雪印乳業株式会社 グルタミン含量の高いペプチド組成物、その製造方法及び経腸栄養剤
WO1994014458A1 (en) * 1992-12-23 1994-07-07 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
JP4059532B2 (ja) * 1994-08-15 2008-03-12 森永乳業株式会社 腸内細菌の体内移行を阻止するペプチド混合物と、このペプチド混合物を含有する組成物
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
JP4011638B2 (ja) * 1994-12-27 2007-11-21 イーエヌ大塚製薬株式会社 経口経腸栄養組成物
US5569680A (en) * 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
JPH09323979A (ja) * 1996-06-04 1997-12-16 Meiji Milk Prod Co Ltd 核酸を用いた免疫調節組成物
GB9701674D0 (en) * 1997-01-28 1997-03-19 Novartis Nutrition Ag Use of organic compounds
JP2001514667A (ja) * 1997-03-17 2001-09-11 タム，ユン ケー． 肝臓脂肪症の予防のための組成物
GB9709082D0 (en) * 1997-05-06 1997-06-25 Ciba Geigy Ag Organic compositions
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
EP0891719A1 (en) 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
AU2186699A (en) * 1998-02-09 1999-08-23 Meiji Milk Products Co., Ltd. Preventives and remedies for intestinal mucosal disorder
US6369252B1 (en) * 1998-02-26 2002-04-09 The University Of Georgia Research Foundation, Inc. Structured lipids
AU771450B2 (en) * 1998-09-11 2004-03-25 Danisco Cultor America, Inc. Reduced calorie plastic fat composition
JP2000119180A (ja) * 1998-10-06 2000-04-25 Nisshin Flour Milling Co Ltd 経腸栄養剤
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives

Also Published As

Publication number Publication date
SK286199B6 (sk) 2008-05-06
BRPI0115451B1 (pt) 2016-07-19
EE200300198A (et) 2003-08-15
IL155840A0 (en) 2003-12-23
NO20032160L (no) 2003-07-14
PL202031B1 (pl) 2009-05-29
IL155840A (en) 2008-11-03
KR20080069280A (ko) 2008-07-25
CZ20031337A3 (cs) 2003-09-17
IS2377B (is) 2008-07-15
HRP20030395A2 (en) 2005-04-30
NO333003B1 (no) 2013-02-11
CZ300129B6 (cs) 2009-02-18
ZA200303722B (en) 2004-04-16
WO2002039978A1 (de) 2002-05-23
ATE272390T1 (de) 2004-08-15
AU2002224848B2 (en) 2006-06-15
DK1337236T3 (da) 2004-12-13
KR20030069172A (ko) 2003-08-25
BR0115451A (pt) 2004-01-06
CA2429270C (en) 2009-08-18
HRP20030395B1 (en) 2011-10-31
SI1337236T1 (en) 2004-12-31
HUP0301386A2 (hu) 2003-09-29
AU2484802A (en) 2002-05-27
RU2295952C2 (ru) 2007-03-27
PL361634A1 (en) 2004-10-04
DE50103152D1 (de) 2004-09-09
DE10057290B4 (de) 2004-01-08
EP1337236A1 (de) 2003-08-27
ES2223015T3 (es) 2005-02-16
CN1477950A (zh) 2004-02-25
NO20032160D0 (no) 2003-05-13
EP1337236B1 (de) 2004-08-04
CA2429270A1 (en) 2002-05-23
US20040097404A1 (en) 2004-05-20
DE10057290A1 (de) 2002-06-06
US7947303B2 (en) 2011-05-24
WO2002039978A8 (de) 2002-07-18
KR100861889B1 (ko) 2008-10-09
HUP0301386A3 (en) 2008-04-28
SK5612003A3 (en) 2003-10-07
NZ525812A (en) 2004-03-26
IS6815A (is) 2003-05-14
JP2004513912A (ja) 2004-05-13
EE05209B1 (et) 2009-10-15
MXPA03004348A (es) 2003-08-19
HU228351B1 (hu) 2013-03-28

Similar Documents

Publication Publication Date Title
PT1337236E (pt) Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas
Pietz et al. Subcutaneous apomorphine in late stage Parkinson’s disease: a long term follow up
BR9908488A (pt) Composição farmacêutica de topiramato
KR920000324A (ko) 필수 지방산 처리법
BR9909672A (pt) uso de um composto medicinal ativo no preparo de um medicamento para o tratamento de hipertensão
BR0106681A (pt) Fórmula pediátrica e métodos para prover nutrição a pacientes pediátricos e para melhorar tolerância em pacientes pediátricos
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BR0008403A (pt) Formulação farmacêutica para administração oral
BR0115985A (pt) Preparação farmacêutica em forma de uma pasta compreendendo um ingrediente ativo ácido-lábil
IT1187687B (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi
KR970061244A (ko) 치매 치료용 약학 조성물
MX9205722A (es) Composicion alimenticia enteral contra el cancer
ES2175663T3 (es) Composiciones farmaceuticas solidas que contienen miltefosina para administracion oral en el tratamiento de la leshmaniasis.
BR0215904A (pt) Métodos e composições para prover glutamina
IT1295408B1 (it) Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
ES2250726T3 (es) Utilizacion de extractos de ginkgo biloba para preparar un medicamento destinado a tratar la sarcopenia.
ATE92756T1 (de) Mittel zur behandlung von keratose.
BR0009875A (pt) Uso de n-acetilcisteìna para a preparação de um medicamento adequado para a administração intravenosa para prevenir a carga oxidativa em pacientes que sofreram diálise
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
PT975581E (pt) Composicoes solidas adequadas para administracao oral compreendendo tartarato de l-carnitina e colina ou de alcanoil-l-carnitina e colina
RU2002108962A (ru) Способ восстановления метаболизма в послеоперационном периоде
Munk Protease paunch?
Girchev et al. Renal Salt and Water Excretion during Endothelin-A Receptor Inhibition in Normtensive and Hypertensive Rats
O'Donovan Bullous Icthyosis